Missing Avatar

Bob Rasulev

Position - Company  
QSAR group leader - Interdisciplinary Center for Nanotoxicity / Department of Chemistry and Biochemistry Jackson State University May 2004 - Dec 2011
Postdoctoral Research Associate - Jackson State University

Chemoinformatics, computational chemistry, quantum chemistry, QSAR, QSPR, Data mining

Show details
May 2004 - Sep 2008
Senior Research Associate - Institute of the Chemistry of Plant Substances

NMR spectroscopy, Natural compounds, Cheminformatics, Drug Design, Structure-Activity studies, computational chemistry, Molecular modeling

Show details
Sep 1993 - May 2003
Scholar - Drew University

Residential School of Medicinal Chemistry

Show details
Jun 2002 - Jun 2002
Research Associate, PhD., computational nanotoxicology - Interdisciplinary Center for Nanotoxicity / Department of Chemistry and Biochemistry Jackson State University

Computational Nanotoxicology, Computational Toxicology, Drug Design methods, QSAR, QSPR, Data Mining, Quantum-mechanical methods, Molecular Docking methods

Show details
Oct 2008 - Present
Degree - University  
Certificate, Medicinal Chemistry - Drew University

Attended the Residential School of Medicinal Chemistry (ResMed) in June, 2002

Show details
2002 - 2002
M.S., Chemistry - Tashkent State University 1988 - 1993
Publication Info
Room temperature synthesis of PbSe quantum dots in aqueous solution: stabilization by interactions with ligands. Primera-Pedrozo OM, Arslan Z, Rasulev B, Leszczynski J Nanoscale. 4(4):1312-20. doi: 10.1039/c2nr11439a. February 21, 2012. View on PubMed.
Use of quantitative structure-enantioselective retention relationship for the liquid chromatography chiral separation prediction of the series of pyrrolidin-2-one compounds. Rasulev B, Turabekova M, Gorska M, Kulig K, Bielejewska A, Lipkowski J, Leszczynski J Chirality. 24(1):72-7. doi: 10.1002/chir.21028. November 26, 2011. View on PubMed.
Structure-activity relationship investigations of leishmanicidal N-benzylcytisine derivatives. Turabekova MA, Vinogradova VI, Werbovetz KA, Capers J, Rasulev BF, Levkovich MG, Rakhimov SB, Abdullaev ND Chem Biol Drug Des. 78(1):183-9. doi: 10.1111/j.1747-0285.2011.01092.x. May 25, 2011. View on PubMed.
Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari TP, Michalkova A, Hwang HM, Toropov A, Leszczynska D, Leszczynski J Nat Nanotechnol. 6(3):175-8. doi: 10.1038/nnano.2011.10. February 13, 2011. View on PubMed.
Aconitum and Delphinium alkaloids of curare-like activity. QSAR analysis and molecular docking of alkaloids into AChBP. Turabekova MA, Rasulev BF, Dzhakhangirov FN, Leszczynska D, Leszczynski J Eur J Med Chem. 45(9):3885-94. doi: 10.1016/j.ejmech.2010.05.042. May 26, 2010. View on PubMed.
QSAR modeling of acute toxicity on mammals caused by aromatic compounds: the case study using oral LD50 for rats. Rasulev B, Kusić H, Leszczynska D, Leszczynski J, Koprivanac N J Environ Monit. 12(5):1037-44. May 2010. View on PubMed.
Choosing safe dispersing media for C60 fullerenes by using cytotoxicity tests on the bacterium Escherichia coli. Cook SM, Aker WG, Rasulev BF, Hwang HM, Leszczynski J, Jenkins JJ, Shockley V J Hazard Mater. 176(1-3):367-73. doi: 10.1016/j.jhazmat.2009.11.039. April 15, 2010. View on PubMed.
Prediction of rate constants for radical degradation of aromatic pollutants in water matrix: a QSAR study. Kusić H, Rasulev B, Leszczynska D, Leszczynski J, Koprivanac N Chemosphere. 75(8):1128-34. doi: 10.1016/j.chemosphere.2009.01.019. February 7, 2009. View on PubMed.
QSAR modeling of acute toxicity by balance of correlations. Toropov AA, Rasulev BF, Leszczynski J Bioorg Med Chem. 16(11):5999-6008. doi: 10.1016/j.bmc.2008.04.055. June 1, 2008. View on PubMed.
Molecular modelling and QSAR analysis of the estrogenic activity of terpenoids isolated from Ferula plants. Rasulev BF, Saidkhodzhaev AI, Nazrullaev SS, Akhmedkhodzhaeva KS, Khushbaktova ZA, Leszczynski J SAR QSAR Environ Res. 18(7-8):663-73. doi: 10.1080/10629360701428631. December 2007. View on PubMed.
Aconitum and Delphinium alkaloids "Drug-likeness" descriptors related to toxic mode of action. Turabekova MA, Rasulev BF, Dzhakhangirov FN, Salikhov SI Environ Toxicol Pharmacol. 25(3):310-20. doi: 10.1016/j.etap.2007.10.035. November 17, 2007. View on PubMed.
Aconitum and Delphinium sp. alkaloids as antagonist modulators of voltage-gated Na+ channels. AM1/DFT electronic structure investigations and QSAR studies. Turabekova MA, Rasulev BF, Levkovich MG, Abdullaev ND, Leszczynski J Comput Biol Chem. 32(2):88-101. doi: 10.1016/j.compbiolchem.2007.10.003. October 24, 2007. View on PubMed.
Structure-toxicity relationships of nitroaromatic compounds. Isayev O, Rasulev B, Gorb L, Leszczynski J Mol Divers. 10(2):233-45. doi: 10.1007/s11030-005-9002-4. May 19, 2006. View on PubMed.
Synthesis, tautomeric states and crystal structure of (Z)-ethyl 2-cyano-2-(3H-quinazoline-4-ylidene) acetate and (Z)-ethyl 2-cyano-2-(2-methyl-3H-quinazoline-4-ylidene) acetate. Tulyasheva M, Rasulev BF, Tojiboev AG, Turgunov KK, Tashkhodjaev B, Abdullaev ND, Shakhidoyatov KM Molecules. 10(9):1209-17. September 30, 2005. View on PubMed.
A QSAR toxicity study of a series of alkaloids with the lycoctonine skeleton. Turabekova MA, Rasulev BF Molecules. 9(12):1194-207. December 31, 2004. View on PubMed.
  • Bob Rasulev hasn't received any ratings yet...